Temi della conferenza
The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit has never been so crucial.
Scientific organizer
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1443975-3?pid=4832
Speakers: Adam Cockrell, Senior Director of Vector Biology, AavantiBio, Alex Murphy, Senior Medical Director, Roche, Beatrice Darimont, Chief Scientific Officer, Cytoo and More
Informazioni ed Iscrizioni:
https://go.evvnt.com/1443975-2?pid=4832
Ms. Emily Birt
CategorieSanità Pubblica (Public Health), Servizi sanitari